Asthma Therapeutics Market Expected To Reach $47.87 Billion By 2030 As Growth Accelerates At 7.6% CAGR
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Asthma Therapeutics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The asthma therapeutics sector has experienced robust expansion in recent years. Its projected growth is from $33.11 billion in 2025 to $35.73 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. Historical market gains were driven by constrained access to biologics, a heavy dependence on short-acting beta agonists, the worldwide increase in asthma prevalence, a greater frequency of hospital and specialty clinic visits, and the growing use of both oral and inhaled treatments.
Over the coming years, the asthma therapeutics market is projected to experience robust expansion. By 2030, its value is anticipated to reach $47.87 billion, reflecting a compound annual growth rate (CAGR) of 7.6%. Several factors are expected to drive this growth during the forecast period, including the emergence of novel biologics and combination therapies, the expansion of telemedicine and digital health monitoring, greater awareness of preventive treatment, improved healthcare accessibility in emerging economies, and increased investment in research and drug development. Key trends shaping the market in the future encompass a growing preference for personalized asthma treatments, higher usage of inhalers and biologics, the broadening of homecare and remote monitoring services, an increased shift toward combination inhaler products, and a stronger emphasis on managing asthma in pediatric and geriatric populations.
Download A Free Sample Report For Comprehensive Market Insights:
Asthma Therapeutics Market Development Factors: Which Trends Are Supporting Demand?
The rising incidence of asthma is anticipated to boost the expansion of the asthma therapeutics market in the future. Asthma is a chronic condition characterized by inflammation and swelling of the airways, which leads to their narrowing and hinders the transport of air from the nose and mouth to the lungs. This increase in asthma cases is largely attributed to growing levels of pollutants, which aggravate the airways and heighten the likelihood of developing the disorder. Asthma therapeutics are utilized to treat the condition by reducing airway inflammation, alleviating symptoms, and preventing attacks. For example, as reported by the UK Parliament, a government body in the United Kingdom, in May 2025, 3,886,879 people over the age of six were diagnosed with asthma in England during 2023-24, representing 6.5% of the population. Consequently, the escalating prevalence of asthma is fueling the growth of the asthma therapeutics market.
Asthma Therapeutics Market Segment Analysis And Revenue Opportunities
The asthma therapeutics market covered in this report is segmented –
1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)
2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications
3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Homecare, Specialty Clinics
Subsegments:
1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide
2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol
3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast
4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline
5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab
6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol
Asthma Therapeutics Market Transformation Trends: Which Innovations Are Driving Change?
Key players in the asthma therapeutics market are concentrating on creating advanced therapies, including anti-inflammatory rescue inhalers, to improve symptom management, control inflammation, and optimize overall disease care. This type of inhaler represents a dual-action treatment that merges a rapid-acting bronchodilator with an inhaled corticosteroid within one device, offering fast airway widening, immediate reduction of inflammation on demand, and prevention of serious asthma episodes. A notable example is AstraZeneca plc, a UK-based biopharmaceutical firm, which debuted AIRSUPRA in January 2024. This FDA-approved rescue inhaler provides quick symptom relief combined with prompt anti-inflammatory effects, using an as-needed dual-mechanism dosage, real-time suppression of airway inflammation, and support in averting lung function deterioration linked to exacerbations. By enhancing asthma management, lowering the likelihood of severe attacks, and boosting overall rescue therapy performance, AIRSUPRA delivers significant clinical benefits.
Asthma Therapeutics Market Leading Players Shaping Industry Direction
Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.
Access The Complete Asthma Therapeutics Market Report:
Asthma Therapeutics Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
